• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂 A 诱导的体内反应。

Lipid A-induced responses in vivo.

机构信息

Tumor Immunology and Immunotherapy Laboratory Inserm U866, University of Burgundy, Dijon, France.

出版信息

Adv Exp Med Biol. 2010;667:69-80. doi: 10.1007/978-1-4419-1603-7_7.

DOI:10.1007/978-1-4419-1603-7_7
PMID:20665201
Abstract

The lipid A analogs used in preclinical studies and clinical trials are not naturally-occurring forms of lipid A; they are synthetic molecules produced to be less toxic than lipid A itself and they do not reproduce the effects of natural lipid A molecules especially in vivo. The responses induced by lipid A analogs are summarized in this chapter: their fate in the blood stream and their toxicity as well as the lipid A tolerance and the tumor immune responses they induce. Lipid A is not found in the mammalian organism under normal circumstances so its use in cancer therapy raises important questions as to its different effects in vivo and its toxicity, particularly in cancer patients. Lipid A has to be injected intravenously (i.v.) to study its effects. Injections of chemically synthesized lipid A in humans and in animals produce sepsis symptoms, such as tachycardia, tachypnea, hyper or hypothermia and leukocytosis or leukopenia. Similar manifestations are observed after injection of purified lipopolysaccharide (LPS), which is why lipid A is usually thought of as the active part of LPS. While lipid A injection is therefore expected to induce reactions similar to septic shock, the lipid A molecules used to treat cancer are not natural forms but analogs, produced by chemical synthesis or genetic engineering, specifically selected for their low toxicity. The in vivo effects of such low-toxicity lipid A analogs are summarized in this chapter.

摘要

在临床前研究和临床试验中使用的脂质 A 类似物不是天然存在的脂质 A 形式;它们是合成分子,旨在降低毒性,并且不能复制天然脂质 A 分子的作用,特别是在体内。本章总结了脂质 A 类似物引起的反应:它们在血液中的命运及其毒性,以及脂质 A 耐受和它们诱导的肿瘤免疫反应。在正常情况下,哺乳动物体内不会发现脂质 A,因此在癌症治疗中使用脂质 A 引起了一些问题,例如其在体内的不同作用及其毒性,尤其是在癌症患者中。为了研究其作用,必须通过静脉内(i.v.)注射来使用脂质 A。在人和动物中注射化学合成的脂质 A 会产生败血症症状,如心动过速、呼吸急促、体温过高或过低以及白细胞增多或减少。在注射纯化的脂多糖(LPS)后也观察到类似的表现,这就是为什么脂质 A 通常被认为是 LPS 的活性部分。因此,尽管预期脂质 A 注射会引起类似于败血症性休克的反应,但用于治疗癌症的脂质 A 分子不是天然形式,而是类似物,通过化学合成或基因工程产生,专门选择其低毒性。本章总结了此类低毒性脂质 A 类似物的体内作用。

相似文献

1
Lipid A-induced responses in vivo.脂 A 诱导的体内反应。
Adv Exp Med Biol. 2010;667:69-80. doi: 10.1007/978-1-4419-1603-7_7.
2
Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.单磷酰脂质 A(MPL)作为抗癌疫苗佐剂的临床结果。
Adv Exp Med Biol. 2010;667:111-23. doi: 10.1007/978-1-4419-1603-7_10.
3
A lipid A analog inhibits LPS-induced cytokine expression and improves survival in endotoxemic mice.一种脂质A类似物可抑制脂多糖诱导的细胞因子表达并提高内毒素血症小鼠的存活率。
Immunopharmacol Immunotoxicol. 1996 Nov;18(4):477-95. doi: 10.3109/08923979609052749.
4
Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A.毒性和无毒形式的脂多糖诱导小鼠肿瘤坏死因子、干扰素-γ及急性致死作用
J Immunol. 1988 Aug 1;141(3):870-4.
5
Lipid A-mediated tolerance and cancer therapy.脂 A 介导的耐受和癌症治疗。
Adv Exp Med Biol. 2010;667:81-99. doi: 10.1007/978-1-4419-1603-7_8.
6
Drug evaluation: E-5564.
IDrugs. 2004 Jun;7(6):582-90.
7
Antitumor activity against Meth A fibrosarcoma and biologic activities of synthetic monosaccharide analogs of lipid A in mice.合成脂质A单糖类似物对小鼠Meth A纤维肉瘤的抗肿瘤活性及生物学活性
Mol Biother. 1990 Jun;2(2):110-4.
8
Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide.牙龈卟啉单胞菌脂多糖天然及合成脂质A的生物学特性
Oral Microbiol Immunol. 2008 Feb;23(1):60-9. doi: 10.1111/j.1399-302X.2007.00392.x.
9
Structural requirements of lipid A for endotoxicity and other biological activities.脂多糖A的内毒素活性及其他生物学活性的结构要求
Crit Rev Microbiol. 1989;16(6):477-523. doi: 10.3109/10408418909104475.
10
A novel lipid A from Halomonas magadiensis inhibits enteric LPS-induced human monocyte activation.一种来自马加迪嗜盐单胞菌的新型脂多糖A可抑制肠道脂多糖诱导的人单核细胞活化。
Eur J Immunol. 2006 Feb;36(2):354-60. doi: 10.1002/eji.200535305.

引用本文的文献

1
Only time will tell: lipopolysaccharide glycoform and biofilm-formation kinetics in species and .时间会证明一切:物种和物种的脂多糖糖型和生物膜形成动力学。
J Bacteriol. 2024 Oct 24;206(10):e0031824. doi: 10.1128/jb.00318-24. Epub 2024 Sep 24.
2
Lipopolysaccharide enhances HSV-1 replication and inflammatory factor release in the ARPE-19 cells.脂多糖增强了ARPE-19细胞中单纯疱疹病毒1型的复制及炎性因子的释放。
Heliyon. 2022 Nov 21;8(11):e11787. doi: 10.1016/j.heliyon.2022.e11787. eCollection 2022 Nov.
3
Pushing the envelope: LPS modifications and their consequences.
推陈出新:LPS 的修饰及其后果。
Nat Rev Microbiol. 2019 Jul;17(7):403-416. doi: 10.1038/s41579-019-0201-x.
4
Function and Biogenesis of Lipopolysaccharides.脂多糖的功能与生物合成
EcoSal Plus. 2018 Aug;8(1). doi: 10.1128/ecosalplus.ESP-0001-2018.
5
TLR4-mediated expression of Mac-1 in monocytes plays a pivotal role in monocyte adhesion to vascular endothelium.Toll样受体4(TLR4)介导的单核细胞中巨噬细胞-1(Mac-1)的表达在单核细胞与血管内皮的黏附中起关键作用。
PLoS One. 2014 Aug 12;9(8):e104588. doi: 10.1371/journal.pone.0104588. eCollection 2014.
6
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis.强化屏障:脂多糖修饰对细菌发病机制的影响。
Nat Rev Microbiol. 2013 Jul;11(7):467-81. doi: 10.1038/nrmicro3047. Epub 2013 Jun 10.
7
Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors.OM-174 是一种脂质 A 类似物的 I 期研究,评估其在难治性实体瘤患者中的免疫反应。
BMC Cancer. 2013 Apr 2;13:172. doi: 10.1186/1471-2407-13-172.